Description: Presented at September 1995 Valuation Actuary Symposium. Discusses the Health Organization Risk-Based Capital formula.

Description: This panel will discuss the current status of NAIC activities with respect to risk-based capital RBC. The potential impact on financial reporting with respect to health products, specifically, indemnity, HMO, disability, and nontraditional products will also be discussed. From the Record of the Society of Actuaries, Vol.21, No. 4a.

Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: Presented at October 1996 Annual Meeting. This session presents and discusses the NAIC's model bill for risk-based capital as it relates to health insurance.

Description: Presented at June 1996 Spring Meeting. This session presents various perspectives on RBC ratios, including pricing, solvency, and the view of company management.

Description: Presented at June 1996 Spring Meeting. A panel of experts discuss risk management and capital management issues for disability insurers and the potential role of reinsurance.

Description: Presented at May 1986 Spring Meeting. This session discussion is about how much surplus is needed, how it is determined, treatment of participating policyholders, approaches for measurement, and regulatory and professional body requirements affecting surplus relief reinsurance.

Description: Presented at May 1985 Spring Meeting. Discusses: Target surplus formulas for specific product lines, Projecting product line surplus needs, How cost of capital is charged to product lines, Criteria to use in allocating capital to or withdrawing capital from specific product lines, Differing techniques appropriate for stock and mutual companies, Differing techniques appropriate for the United States and Canada, How capital allocation relates to regulatory requirements, How capital allocation relates to competition in other industries.

Description: The management of the investments of an insurance enterprise has undergone a considerable evolution since the pioneering work of Redington in the mid 20th century. Best practices have evolved to incorporate ever more complex insurance liabilities, expanding investment asset classes and global market opportunities. Strategic asset allocation (SAA), liability driven investing, and other robust optimization approaches form the core of the professional management of insurance company investments.

Description: Presented at September 1995 Valuation Actuary Symposium. Discusses surplus management, including RBC, the capital management process and techniques, allocations of capital, raising capital, and rating agencies.